Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Colorectal cancer burden rises in younger age groups

Key clinical point: Current trends in the incidence and mortality of colorectal cancer in the United States suggest the disease will become one that largely affects young and middle-aged adults.

Major finding: Among individuals aged 65 years or older, colorectal cancer incidence dropped by 3.3% per year from 2011 through 2016, but the incidence accelerated in individuals aged 50-64 years (1% per year) and those younger than 50 years (2.2% per year).

Study details: A population-based cohort study using Surveillance, Epidemiology, and End Results registry data through 2017.

Disclosures: The authors disclosed financial affiliations with the American Cancer Society, which funded the study, as well as Array Biopharma, Bayer, RGenix, Tesaro, and Seattle Genetics.

Citation:

Siegel RL et al. CA Cancer J Clin. 2020 Mar 5. doi: 10.3322/caac.21601.